Use Of Cholesterol Drugs By Patients Without High Cholesterol Level

Use Of Cholesterol Drugs By Patients Without High Cholesterol Level.
When the US Food and Drug Administration in February 2010 approved the use of the cholesterol-lowering statin stimulant Crestor for some males and females with stable cholesterol levels, cardiologist Dr Steven E Nissen cheered the decision. "You have to go with the meticulous evidence," said Nissen, who is chairman of cardiovascular medication at the Cleveland Clinic neosize medicine in abudhabi. "A clinical trial was done and there was a substantial reduction in morbidity and mortality in rank and file treated with this drug".

But Dr Mark A Hlatky, a professor of healthiness research and policy and medicine at Stanford University, has expressed doubts about the FDA move. He worries that more mobile vulgus will rely on a pill rather than diet and exercise to cut their heart risk, and also points to studies linking statins such as Crestor to muscle troubles and even diabetes enhancement. "I haven't seen anything that changes my affronted by about that".

So, will millions of flourishing Americans soon join the millions of less-than-healthy subjects who already take these blockbuster drugs? The FDA's Feb 9 approval of expanded use of rosuvastatin (Crestor) was based on results of the JUPITER study, which tangled more than 18000 people and was financed by the drug's maker, AstraZeneca. People in the conditional who took the drug for an average of 1,9 years had a 44 percent slash risk of heart attack, stroke and other cardiovascular problems compared to those who took a placebo - results so first-rate that the trial was cut short. Based on JUPITER, an FDA monitory committee voted 12 to 4 in December to approve widened use of the drug.

The population in the trial included men over 50 and women over 60 with normal or near-normal cholesterol levels. However, these individuals did have intoxication levels of C-reactive protein, a marker of inflammation that has also been linked to cardiovascular problems. They also had at least one other heartlessness risk factor, such as obesity or high blood pressure.

For that peculiar group, Crestor makes sense. "Over a five-year period of time, you baffle one death or minor stroke for every 25 people treated". Whether or not others with normal cholesterol should learn Crestor or another statin remains unclear. "Not everyone with normal cholesterol should be treated. You should give it to ancestors with a high enough risk".